- Study protocol
- Open Access
- Open Peer Review
The effect of pelvic physiotherapy on reduction of functional constipation in children: design of a multicentre randomised controlled trial
BMC Pediatrics volume 13, Article number: 112 (2013)
Functional constipation is a common disorder worldwide and is found in all paediatric age groups. Functional constipation can be caused by delayed colonic transit or dysfunction of the pelvic floor muscles. Standard medical care in paediatric practice is often based on clinical experience and mainly consists of a behavioural approach and toilet training, along with the prescription of laxatives. Evidence to evaluate the effectiveness of pelvic physiotherapy for this complaint is lacking.
A two-armed multicentre randomised controlled trial has been designed. We hypothesise that the combination of pelvic physiotherapy and standard medical care will be more effective than standard medical care alone for constipated children, aged 5 to 17 years. Children with functional constipation according to the Rome III will be included. Web-based baseline and follow-up measurements, scheduled at 3 and 6 months after inclusion, consist of the numeric rating scale in relation to the perceived severity of the problem, the Strength and Difficulties Questionnaire and subjective improvement post-intervention (global perceived effect). Examination of the pelvic floor muscle functions, including digital testing and biofeedback, will take place during baseline and follow-up measurements at the physiotherapist. The control group will only receive standard medical care, involving at least three contacts during five months, whereas the experimental group will receive standard medical care plus pelvic physiotherapy, with a maximum of six contacts. The physiotherapy intervention will include standard medical care, pelvic floor muscle training, attention to breathing, relaxation and awareness of body and posture. The study duration will be six months from randomisation, with a three-year recruitment period. The primary outcome is the absence of functional constipation according to the Rome III criteria.
This section discusses the relevance of publishing the study design and the development of the presented physiotherapy protocol. It also addresses difficulties when interpreting the literature with regard to the effectiveness of biofeedback, potential confounding, and future research indications. To our knowledge, this article is the first to describe the design of a randomised controlled trial among children with constipation to assess the effect of pelvic physiotherapy as an add-on to standard medical care.
Current Controlled Trials NL30551.068.09
Constipation is a common disorder worldwide, affecting 0.7% to 29.6% (median 12%) of children aged 0–18 years, and is found in all paediatric age groups with a severity that ranges from mild to severe and a duration that ranges from brief to chronic [1–4]. Symptoms of constipation are included in the Rome III criteria (Table 1), which were formulated by paediatric gastroenterologists in 2006 [3, 5]. Constipation has a major impact on a child’s psychosocial functioning. About 40% of these children are burdened by emotional problems, such as eating disorders, truancy, family problems, social isolation and depression [6–10].
The pathophysiology of childhood constipation is multifactorial and not yet fully understood. No clear organic cause is found in over 90% of the children who suffer from constipation, so-called functional constipation (FC). FC includes delayed colonic transit and dyssynergic defaecation. In the majority of children dyssynergic defaecation is the cause for their complaints, and refers to an incomplete evacuation of faeces due to paradoxical contraction of, or failure to relax the pelvic floor muscles when straining and/or a failure to increase intra rectal pressure [11, 12]. In some patients, delayed colonic transit may be the result of dyssynergic defaecation. Approximately 50% of children show this abnormal defecation pattern . Withdrawal of stool, hard painful defecation or fear of stool, resulting in a vicious circle, is the most commonly proposed explanation of the aetiology of dyssynergic constipation in children [4, 7, 12, 14–16].
The standard medical care (SMC) for FC children in routine paediatric practice is often based on clinical experience and mainly consists of a behavioural approach and toilet training along with the prescription of laxatives, sometimes supported by disimpaction or a high fibre diet [7, 10, 14, 17, 18]. Despite intensive medical and behavioural treatment long-term follow-up studies have shown that 50% of the children still have complaints of constipation after five year follow up .
Since dyssynergic dysfunction of the pelvic floor is the major reason for FC in children, it is thought that pelvic physiotherapists, who have specific expertise in treating dyssynergic dysfunction, as musculoskeletal experts might play an important role to increase the success rate. All prerequisites for proper micturition and defecation, such as a relaxed toilet posture [18, 20], adequate straining [18, 21, 22] and trunk stability [23–26], are trained extensively. Pelvic floor muscle training involves training the right use of the pelvic floor muscles (PFM) during contracting and straining, breathing and changes in abdominal pressure [21, 22, 27]. In case of (urine) incontinence, the treatment can be extended with additional PFM exercises.
Standard pelvic physiotherapy (PPT) care for the constipated child has not been described. In most cases, PPT consists of education, demystification, the use of micturition and defecation diaries, toilet training, breathing and relaxation exercises and pelvic floor muscle training (PFMT), with PFMT including exercises and biofeedback (BF) [28, 29].
Trial design, hypothesis and research
To date, there has been little scientific evidence evaluating the effectiveness of pelvic physiotherapy (PPT) in childhood constipation [7, 14, 29, 30]. Therefore we designed a two-armed multicentre randomised controlled clinical trial (RCT). We hypothesise that the combination of standard medical care (SMC) and PPT will prove more effective than SMC alone for the treatment of FC in children aged 5 to 17 years.
Secondary research questions are: (1) Does PPT add to the child’s quality of life, as defined by the strengths and difficulties questionnaire (SDQ), the numeric rating scale (NRS) in relation to the perceived severity of the problem and the global perceived effect (GPE), (2) what values of the pelvic floor muscle function (PFMF) in children can be defined based on the results of the study in clinically relevant subgroups, according to the international continence society (ICS) criteria.
This study was registered in the Netherlands National Trial Register (NL30551.068.09). The Medical Ethics Committee of the Maastricht University Medical Centre has approved the study. This study has been designed in accordance with the Helsinki Accords and the Dutch Medical Research Involving Human Subjects Act (WMO).
Framework of the study
A child’s participation to the study starts and ends with a visit to a paediatrician. In our multicentre randomised controlled trial, the control group will receive only standard medical care (SMC) (Figure 1) whereas the experimental group will have SMC supplemented with PPT (Figure 2). The control group will have at least three contacts with the paediatrician in five months while the experimental group will have a maximum of six contacts with the physiotherapist. The study duration will be six months from randomisation, with a three-year recruitment period.
Measurement and timing
Web-based measurements will be obtained before the first visit to the physiotherapist (M-WB 1), three months after randomisation (M-WB 2) and before the final visit to the physiotherapist (M-WB-3) (Figure 1). Shortly before randomisation (M-PPT 1) and at six month, adjacent to M-WB 3, measurements at the physiotherapist will take place (M-PPT 2). After M-PPT 2 a final visit at the paediatrician is scheduled.
Web-based measurements include a structured patient reported outcome, which assesses the presence of the Rome III criteria and laxative use, co morbidity (such as urinary problems and abdominal pain), the Strength and Difficulties Questionnaire (SDQ), the numeric rating scale (with regard to experienced burden) and a two weeks diary. At follow-up (M-WB 2 and M-WB 3) the web-based measurements are supplemented with the global perceived effect (GPE).
At the last visit at the paediatrician, use of laxatives and the presence of Rome-III-criteria (primary outcome) are recorded.
Children living in the Netherlands and referred to pelvic physiotherapy by paediatricians from various hospitals will be enrolled in this study.
(1) age 5–17 years, (2) functional constipation according to the Rome III criteria, (3) attending regular schools, (4) parent(s) sign(s) an informed consent, (5) children aged over 11 years sign an informed consent themselves, and (6) the child and parent(s) are motivated to participate in the study.
(1) prior physiotherapy because of defecation or micturition complaints, (2) urotherapy by another professional (nurse, psychologist etc.) at the start of the study, (3) severe delay in motor skills development, (4) endocrine and metabolic disorders (hypothyroidism, hypercalcemia, diabetes mellitus, diabetes insipidus), (5) neurological and psychiatric disorders (spina bifida, cerebral palsy, anorexia nervosa, autism or PDD-NOS), (6) Down Syndrome, (7) Hirschsprung disease, (8) at least 14 points on the Strength and Difficulties Questionnaire, (9) drug-induced constipation and (10) intestinal surgery (except appendectomy).
Standard medical care
Standard medical care, provided by paediatricians, will be given in accordance with the Dutch guideline for constipated children (Figure 2) . Essentially, standard medical care consists of education and demystification about the complaint, food, and drink and physical activity as well as toilet training and the use of diaries and laxatives . Usual care laxative use in children with faecal impaction and older than two years is 1–1.5 g /kg per day for a maximum of seven days. The maintenance dose is 0.3 to 0.8 g/kg per day . The dose will be tailored to individual needs during the trial with guidance of the Bristol Stool Form Scale .
The Dutch pelvic physiotherapy protocol
In order to standardise pelvic physiotherapy (PPT) for these children, a survey was first held among 63 Dutch specialised physiotherapists. Extensive agreement existed on providing information, the use of diaries, toilet training, pelvic floor muscle training and biofeedback. On the basis of the survey a provisional PPT protocol was designed in consultation with 25 physiotherapists who were experienced in treating constipated children, using the data from the survey and the literature (Figure 3). Next, the Delphi method was used to discuss, improve and practise the interim protocol during three meetings with all participating physiotherapists. The resulting Dutch pelvic physiotherapy protocol (DPPP) (Figure 4) provides standardisation of intake and intervention.
In this study, according to the DPPP, the PPT intake will consist of medical history tracking, physical examination of at least balance and stability according to M-ABC-2, [24, 32, 33] assessment of breathing and straining [21, 22, 25, 26], the Beighton hyper mobility score [34, 35] and assessment of the pelvic floor muscles and their function [12, 29].
The PPT intervention, with a maximum of six sessions will include standard medical care (education, demystification, toilet training, use of diaries and guiding the use of laxatives without intervention of the paediatrician and pelvic floor muscle training using exercise therapy, myofeedback (MFB) and rectal balloon training (RBT), as well as attention to breathing, relaxation and awareness of body and body posture. Awareness of urge and coordination of the PFM during filling and straining will be practised. During MFB, the child will receive information about the activity of the pelvic floor muscles by means of a visual display or a beeping sound. Children with an insensitive rectum will be taught to excrete smaller volumes and to repeat this action until a more normal level of sensory threshold is reached. In the case of an incorrect straining technique, RBT can be applied to learn to strain adequately.
The PPT will be patient-tailored and the sequence and intensity of PPT depends on the child's age and motivation, parents` motivation, co-morbidity and cognition. Toilet training, including pelvic floor muscle training, will be the basis of the PPT and requires considerable attention. All exercises, materials and methods will be presented in a playful manner and in accordance with the children’s age, loco motor skills and perceptions [24, 28, 29, 36].
Primary outcome measure
The primary outcome measure is the absence of FC according to the Rome III criteria. The use of less than 10 g of macrogol 3350 or 4000 a day, as a maintenance dose, is allowed.
Secondary outcome measures
Numeric rating scale
The two single-item 1–10 numeric rating scales (NRS) measure perceived severity of the problem by the parents and estimate the child’s experience .
Strength and Difficulties Questionnaire (SDQ).
The validated SDQ has two versions, one for parents (7–19 years) and one for children (11 years and over), which were developed using the ‘diagnostic and static manual of mental disorders classification’ for psychosocial problems, as these problems (anxiety, depression, behavioural disorders and attention deficit hyperactivity disorders) are relatively common among young people. The total score ranges from 0 to 40 points, with established cut-off points at 0–10 (normal), 11–13 (borderline, presence of less serious issues) and above 14 (high) [38–40].
Global perceived effect
The global perceived effect (GPE) instrument is a subjective score that simply shows the perceived change in symptoms during and after treatment, ranging from 1 (much worse) to 9 (complaints have disappeared). The GPE will be administered at MT-WB 2 and MT-WB 3 before the final visit to the physiotherapist.
Pelvic floor muscle function
The following measurements will be done by the physiotherapist at the second (MT-PPT 1) and final visit (MT-PPT 2).
Digital testing will be used to measure the ability and reflex action of the pelvic floor muscles (PFM) at rest and during contraction, cough and straining to defecate. The tone of the internal and external anal sphincters and puborectalis muscle will be palpated, and the sensitivity, anal reflex and presence of stool evaluated. Strength, endurance, coordination and the ability to close the rectum will be evaluated by asking the child to contract and relax the PFM, and then to hold the contraction for 30 seconds. At the same time, the pelvic physiotherapist will assess whether the child is contracting the extra-pelvic muscles, like the abdominal, gluteal and adductor muscles.
Myofeedback uses the electromyographic (EMG) signal of the pelvic floor muscles. The level of the EMG signal should increase while contracting, whereas the signal should decrease at relaxation [15, 17, 41, 42]. Given the absence of an assessment instrument to define proper muscle tone of children's pelvic floor, parameters for the male adults will be used [28, 29, 36, 43].
For the purpose of this study, the small intra-anal PelviRing Anal Probe will be used.
The baseline tone of the puborectalis, the maximum strength, and maximum strength after 30 seconds, the tone during straining, the fast and slow twitch and the ability to relax will be measured.
Values are considered abnormal when: (1) The resting tone is higher than 5 μV (hypertonic) or lower than 2 μV (hypotonic), (2) the sub maximal strength after 30 seconds is not equal to the resting tone, (3) the tone during straining is over 5 μV, (4) onset over 0.2 seconds, (5) offset over 0.2 seconds, (6) the resting tone after testing is higher than 5 μV and (7) the tone fluctuates.
Rectal Balloon Catheter
Rectal balloon training (RBT) will be used to develop awareness of the sensory threshold and to strain in a proper way. A neoprene rectal balloon attached to a syringe will be introduced into the rectum and slowly inflated with air to imitate rectal contents. Next, the child will be requested to excrete the balloon, as it would do during defecation. Attention will be paid to the effect of the pelvic floor muscles on sensory threshold, urge sensation, maximum tolerated volume and straining. Satisfactory (reflex) reaction of the external anal sphincter or overreactions of the pelvic floor muscles and of the extra-pelvic muscles like those of the trunk, legs, arms or head are recorded at first sensation, urge and maximum urge. The method of straining is left to the child. The ability to strain sufficiently to defecate is recorded. Absence of reaction of the external anal sphincter, immediately before or at sensory threshold, urge and maximum tolerated volume, will be considered abnormal, as are overreactions of the pelvic floor muscles or the extra-pelvic muscles at straining.
Power of the study
The sample size of this study has been calculated on the basis of a clinical difference of minimal relevance in terms of proportions. The success rate (absence of FC) of the controls has been set at 60% [30, 44–46]. There is no published PPT success rate but it is estimated to be 75%. Based on a two-sided effect, an alpha of 0.05, a power of 80% and an expected drop-out rate of 20%, at least 367 children should be enrolled in this study.
Randomisation and blinding
Randomisation will be based on a list of random numbers generated by a computer in a 1:1 ratio. Concealed randomisation will take place immediately after the second visit to the physiotherapist. Blinding of practitioners, children and outcome assessor is impossible. However, the investigator and parents are blinded for the web-based and PPT baseline measurements and the diary data.
After checking for missing data and testing for normality, group differences will be analysed using the Pearson Chi-square test, or likelihood ratio in the case of dichotomous outcomes. Continuous outcomes will be analysed using the independent samples t-test or the Mann–Whitney U test. Adjusted group differences will be analysed using multivariable logistic regression with ordinal variables transformed into dummies, taking into account possible differences in mean number of sessions. Finally, subgroup analyses will be done to establish normal values and observed differences in effectiveness for relevant clinical subgroups.
Data analysis will be done according to the intention-to-treat principle. Characteristics of the study population at baseline will be described. Potential effect modifiers like age and gender [10, 14], as well as potential confounders like urinary incontinence, enuresis and abdominal pain will be taken into account [17, 47–51]. To assess selection bias, responders and nonresponders will be compared in terms of relevant clinical and demographic variables. Data analysis will be carried out using SPSS version 19.0 (SPSS Inc., Chicago, Illinois). A two-tailed p-value of 0.05 will be considered statistically significant.
Why publish a study protocol? This study aims to show that pelvic physiotherapy in combination with standard medical care is more effective than standard medical care alone in constipated children. To our knowledge, this article is the first to describe the design of an RCT among children with FC to assess the effect of PPT as an add-on to SMC. The Dutch Pelvic Physiotherapy Protocol (DPPP) presented here is based on the available literature, a survey and a Delphi procedure among experts. Exchanging knowledge and expertise with other researchers is important in order to prevent duplicate research. Consequently, it has been decided to publish the study protocol prior to achieving results.
The DPPP was developed between 2007 and 2009. Given that no studies have so far been published on the effect of PPT in childhood constipation  and that a repeat survey on standard PPT among 49 Dutch physiotherapists in 2011 did not yield substantial differences compared to the 2007 survey, we feel this protocol is as up-to-date as possible.
In the absence of an evaluation tool, we will use parameters for male adults to define the proper childhood pelvic floor muscle functions. These values are expected to be similar to the children’s, as is also the opinion of the experts and the literature .
Confounding in our trial may arise due to the Hawthorne-effect as a result of differences in number of the protocolised contacts. Although it is expected, based on experience, that the mean number of treatment sessions will be equal, adjusted group differences will be analysed.
Biofeedback, as a modality of PPT, is an umbrella term in the literature, covering different types of treatment, e.g. manometry (MT), myofeedback (electromyography feedback) (MFB), rectal balloon training (RBT), functional electric stimulation, flowmetry and ultrasound scan. It is administered in various ways depending on availability, costs, setting (clinic/private, discipline involved [physiotherapist/nurse/medical doctor]) and country. There are also differences in the biofeedback method used (peri-anal surface electrodes, intra-anal probes, anal manometry or RBT), the practitioner administering it (gastroenterologist, paediatrician or psychologist), number of treatments and outcome [53–58]. Furthermore, trials show a substantial lack of quality and harmonisation, resulting in heterogeneous treatment protocols and difficulties when interpreting the findings reported in the literature. Mixed results of BF treatment for constipation have been reported [24, 54, 57, 59, 60].
FC caused by pelvic floor dysfunction or delayed colonic transit can manifest itself as a single or combined problem . The behavioural approach, concentrating on toilet training and learning to recognise signals from the body such as the urge to defecate, is important for all constipated children . To date, the relationship between pelvic floor muscles, breathing, trunk control and posture [21, 22, 25, 26] has been largely ignored. Therefore, we feel that PFM training must be included in the treatment and should be the starting point of the therapy, rather than being studied as a single modality.
In order to standardise pelvic physiotherapy and minimise information bias, the treatment protocol has been designed in consultation with all participating specialised physiotherapists, who are experienced in treating constipated children.
As with most physiotherapeutic and medical interventions, the practitioner and patient will not be blinded to the treatment interventions. However, the investigator and patient will be blinded for the web-based and PPT baseline measurements and diary data.
Potential confounders will be the presence of urinary incontinence, enuresis, abdominal pain and the use of laxatives [1, 18, 47]. The presence of incontinence, enuresis and pain can influence the perception of patients' quality of life or may distort the SDQ and GPE scores.
Patients' compliance with the home toilet training and the use of laxatives will be monitored, as it determines the therapy intensity and, indirectly, the success of the therapy. Finally, the use of laxatives will be taken into account, as it can influence the number of stool events and consistency. The results of this trial will be used to evaluate the proposed Dutch pelvic physiotherapy protocol and to determine normal values for the pelvic floor muscle function in children. These outcomes will serve as recommendations in the guideline on PPT in constipated children, which will be developed using the standard method for clinical practice guideline development of the Royal Dutch Society for Physical Therapy (KNGF).
The web-based medical software had been developed by Fastguide, Bergen op Zoom, the Netherlands.
Dutch pelvic physiotherapy protocol
Global perceived effect
International continence society
Royal Dutch Society for Physical Therapy
Numeric rating scale
Measurement at PPT practice
Pelvic floor muscles
Pelvic floor muscle training
Rectal balloon training
Randomised controlled trial
Strengths and Difficulties Questionnaire
Standard medical care.
Mugie SM, Benninga MA, Di Lorenzo C: Epidemiology of constipation in children and adults: a systematic review. Best practice & research Clinical gastroenterology. 2011, 25 (1): 3-18. 10.1016/j.bpg.2010.12.010.
Mugie SM, Di Lorenzo C, Benninga MA: Constipation in childhood. Nature reviews Gastroenterology & hepatology. 2011, 8 (9): 502-511. 10.1038/nrgastro.2011.130.
Drossman DA: The functional gastrointestinal disorders and the rome III process. Gastroenterology. 2006, 130 (5): 1377-1390. 10.1053/j.gastro.2006.03.008.
van den Berg MM, Benninga MA, Di Lorenzo C: Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006, 101 (10): 2401-2409. 10.1111/j.1572-0241.2006.00771.x.
Drossman DA, Dumitrascu DL: Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006, 15 (3): 237-241.
Benninga MA: Quality of life is impaired in children with functional defecation disorders. J Pediatr (Rio J). 2006, 82 (6): 403-405. 10.2223/JPED.1570.
Brazzelli M, Griffiths P: Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children. Cochrane Database Syst Rev. 2006, 2: CD002240
Feinberg L, Mahajan L, Steffen R: The constipated child: is there a correlation between symptoms and manometric findings?. J Pediatr Gastroenterol Nutr. 2008, 47 (5): 607-611. 10.1097/MPG.0b013e3181684c94.
Joinson C, Heron J, Butler U, Von Gontard A: Psychological differences between children with and without soiling problems. Pediatrics. 2006, 117 (5): 1575-1584. 10.1542/peds.2005-1773.
Rajindrajith S, Devanarayana NM, Benninga MA: Children and adolescents with chronic constipation: How many seek healthcare and what determines it?. J Trop Pediatr. 2011, 58 (4): 280-285.
Chiarioni G, Heymen S, Whitehead WE: Biofeedback therapy for dyssynergic defecation. World J Gastroenterol. 2006, 12 (44): 7069-7074.
Whitehead WE, Bharucha AE: Diagnosis and treatment of pelvic floor disorders: what's new and what to do. Gastroenterology. 2010, 138 (4): 1231-1235. 10.1053/j.gastro.2010.02.036. 1235 e1231-1234
Van Dijk M, Benninga MA, Grootenhuis MA, Nieuwenhuizen AM, Last BF: Chronic childhood constipation: a review of the literature and the introduction of a protocolized behavioral intervention program. Patient Educ Couns. 2007, 67 (1–2): 63-77.
Benninga MA, Voskuijl WP, Taminiau JA: Childhood constipation: is there new light in the tunnel?. J Pediatr Gastroenterol Nutr. 2004, 39 (5): 448-464. 10.1097/00005176-200411000-00002.
Culbert TP, Banez GA: Integrative approaches to childhood constipation and encopresis. Pediatr Clin North Am. 2007, 54 (6): 927-947. 10.1016/j.pcl.2007.09.001.
Whitehead WE, Di Lorenzo C, Leroi AM, Porrett T, Rao SS: Conservative and behavioural management of constipation. Neurogastroenterol Motil. 2009, 21 (Suppl 2): 55-61.
Plunkett A, Phillips CP, Beattie RM: Management of chronic functional constipation in childhood. Paediatr Drugs. 2007, 9 (1): 33-46. 10.2165/00148581-200709010-00004.
Nederlandse Vereniging voor Kindergeneeskunde: CBO-richtlijn 'Obstipatie bij kinderen van 0–18 jaar'. 2010, http://www.nvk.nl/Kwaliteit/Richtlijnenenindicatoren/Richtlijnen/Obstipatiebijkinderen/tabid/345/language/nl-NL/Default.aspx,
Bongers ME, Benninga MA: Long-term follow-up and course of life in children with constipation. J Pediatr Gastroenterol Nutr. 2011, 53 (Suppl 2): S55-56.
Tabbers MM, Boluyt N, Berger MY, Benninga MA: Clinical practice : diagnosis and treatment of functional constipation. European journal of pediatrics. 2011, 170 (8): 955-963. 10.1007/s00431-011-1515-5.
Hodges PW, Sapsford R, Pengel LH: Postural and respiratory functions of the pelvic floor muscles. Neurourol Urodyn. 2007, 26 (3): 362-371. 10.1002/nau.20232.
Sapsford RR, Hodges PW: Contraction of the pelvic floor muscles during abdominal maneuvers. Arch Phys Med Rehabil. 2001, 82 (8): 1081-1088. 10.1053/apmr.2001.24297.
Lederman E: The myth of core stability. J Bodyw Mov Ther. 2010, 14 (1): 84-98. 10.1016/j.jbmt.2009.08.001.
Chase JW, Stillman BC, Gibb SM, Clarke MC, Robertson VJ, Catto-Smith AG, Hutson JM, Southwell BR: Trunk strength and mobility changes in children with slow transit constipation. J Gastroenterol Hepatol. 2009, 24 (12): 1876-1884. 10.1111/j.1440-1746.2009.05940.x.
Sapsford R: Rehabilitation of pelvic floor muscles utilizing trunk stabilization. Man Ther. 2004, 9 (1): 3-12. 10.1016/S1356-689X(03)00131-0.
Sapsford RR, Richardson CA, Maher CF, Hodges PW: Pelvic floor muscle activity in different sitting postures in continent and incontinent women. Arch Phys Med Rehabil. 2008, 89 (9): 1741-1747. 10.1016/j.apmr.2008.01.029.
Shafik A, El Olfat S, Shafik AA, Shafik IA: Contraction of gluteal maximus muscle on increase of intra-abdominal pressure: role in the fecal continence mechanism. Surg Innov. 2007, 14 (4): 270-274.
Van Engelenburg-Van Lonkhuyzen ML: Dutch association for physical therapy for pelvic floor disorders and Pre- and postnatal healthcare. Beroepscompetentieprofiel bekkenfysiotherapeut. 2008
Bo K, Berghmans B, Morkved S, Kampen Van M: Evidence-based physical therapy for the pelvic floor, bridging science and clinical practice. 2007, Butterworth, Heinemann, Elsevier, 395-408.
Van Dijk M, Bongers ME, De Vries GJ, Grootenhuis MA, Last BF, Benninga MA: Behavioral therapy for childhood constipation: a randomized, controlled trial. Pediatrics. 2008, 121 (5): e1334-1341. 10.1542/peds.2007-2402.
Riegler G, Esposito I: Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol. 2001, 5 (3): 163-164.
Wagner MO, Kastner J, Petermann F, Bos K: Factorial validity of the movement assessment battery for children-2 (age band 2). Res Dev Disabil. 2011, 32 (2): 674-680. 10.1016/j.ridd.2010.11.016.
Schulz J, Henderson SE, Sugden DA, Barnett AL: Structural validity of the movement ABC-2 test: factor structure comparisons across three age groups. Res Dev Disabil. 2011, 32 (4): 1361-1369. 10.1016/j.ridd.2011.01.032.
Smits-Engelsman B, Klerks M, Kirby A: Beighton score: a valid measure for generalized hypermobility in children. J Pediatr. 2011, 158 (1): 119-123. 10.1016/j.jpeds.2010.07.021. 123 e111-114
van der Giessen LJ, Liekens D, Rutgers KJ, Hartman A, Mulder PG, Oranje AP: Validation of beighton score and prevalence of connective tissue signs in 773 dutch children. J Rheumatol. 2001, 28 (12): 2726-2730.
Voorham-Van Der Zalm PJ: Department of urology. Towards evidence based practice in pelvic floor physiotherapy. 2008, Leiden: Leiden University Medical Centre, 49-66.
Streiner DL, Norman GF: Health measurement scales a practical guide to their development and use. 2003, Oxford University Press
Rothenberger A, Becker A, Erhart M, Wille N, Ravens-Sieberer U: Psychometric properties of the parent strengths and difficulties questionnaire in the general population of german children and adolescents: results of the BELLA study. Eur Child Adolesc Psychiatry. 2008, 17 (Suppl 1): 99-105.
Muris P, Meesters C, Eijkelenboom A, Vincken M: The self-report version of the strengths and difficulties questionnaire: its psychometric properties in 8- to 13-year-old non-clinical children. Br J Clin Psychol. 2004, 43 (Pt 4): 437-448.
Muris P, Meesters C, van den Berg F: The strengths and difficulties questionnaire (SDQ)–further evidence for its reliability and validity in a community sample of dutch children and adolescents. Eur Child Adolesc Psychiatry. 2003, 12 (1): 1-8.
Chiarioni G, Whitehead WE: The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol. 2008, 5 (7): 371-382. 10.1038/ncpgasthep1150.
Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE: Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009, 52 (10): 1730-1737. 10.1007/DCR.0b013e3181b55455.
Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C, Laycock J, Lim PH, Van Lunsen R, Nijeholt GL A, et al: Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the international continence society. Neurourol Urodyn. 2005, 24 (4): 374-380. 10.1002/nau.20144.
Pijpers MA, Tabbers MM, Benninga MA, Berger MY: Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures. Arch Dis Child. 2009, 94 (2): 117-131.
Berquist WE: Biofeedback therapy for anorectal disorders in children. Semin Pediatr Surg. 1995, 4 (1): 48-53.
van der Plas RN, Benninga MA, Buller HA, Bossuyt PM, Akkermans LM, Redekop WK, Taminiau JA: Biofeedback training in treatment of childhood constipation: a randomised controlled study. Lancet. 1996, 348 (9030): 776-780. 10.1016/S0140-6736(96)03206-0.
Soderstrom U, Hoelcke M, Alenius L, Soderling AC, Hjern A: Urinary and faecal incontinence: a population-based study. Acta Paediatr. 2004, 93 (3): 386-389. 10.1111/j.1651-2227.2004.tb02966.x.
Bael AM, Benninga MA, Lax H, Bachmann H, Janhsen E, De Jong TP, Vijverberg M, Van Gool JD: Functional urinary and fecal incontinence in neurologically normal children: symptoms of one 'functional elimination disorder'?. BJU Int. 2007, 99 (2): 407-412. 10.1111/j.1464-410X.2006.06528.x.
Bauer SB, Neveus T, Von Gontard A, Hoebeke P, Bower W, Jorgensen TM, Rittig S, Walle JV, Yeung CK, Djurhuus JC: Standardizing terminology in pediatric urology. J Pediatr Urol. 2007, 3 (2): 163-10.1016/j.jpurol.2006.10.002.
Bower WF, Yip SK, Yeung CK: Dysfunctional elimination symptoms in childhood and adulthood. J Urol. 2005, 174 (4 Pt 2): 1623-1627. discussion 1627–1628
Nurko S, Scott SM: Coexistence of constipation and incontinence in children and adults. Best Pract Res Clin Gastroenterol. 2011, 25 (1): 29-41. 10.1016/j.bpg.2010.12.002.
Desantis DJ, Leonard MP, Preston MA, Barrowman NJ, Guerra LA: Effectiveness of biofeedback for dysfunctional elimination syndrome in pediatrics: a systematic review. J Pediatr Urol. 2011, 7 (3): 342-348. 10.1016/j.jpurol.2011.02.019.
Borowitz SM, Cox DJ, Sutphen JL, Kovatchev B: Treatment of childhood encopresis: a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr. 2002, 34 (4): 378-384. 10.1097/00005176-200204000-00012.
Sunic-Omejc M, Mihanovic M, Bilic A, Jurcic D, Restek-Petrovic B, Maric N, Dujsin M, Bilic A: Efficiency of biofeedback therapy for chronic constipation in children. Coll Antropol. 2002, 26 (Suppl): 93-101.
Nolan T, Catto-Smith T, Coffey C, Wells J: Randomised controlled trial of biofeedback training in persistent encopresis with anismus. Arch Dis Child. 1998, 79 (2): 131-135. 10.1136/adc.79.2.131.
Loening-Baucke V: Biofeedback treatment for chronic constipation and encopresis in childhood: long-term outcome. Pediatrics. 1995, 96 (1 Pt 1): 105-110.
Van Ginkel R, Buller HA, Boeckxstaens GE, van Der Plas RN, Taminiau JA, Benninga MA: The effect of anorectal manometry on the outcome of treatment in severe childhood constipation: a randomized, controlled trial. Pediatrics. 2001, 108 (1): E9-10.1542/peds.108.1.e9.
van der Plas RN, Benninga MA, Redekop WK, Taminiau JA, Buller HA: Randomised trial of biofeedback training for encopresis. Arch Dis Child. 1996, 75 (5): 367-374. 10.1136/adc.75.5.367.
Palsson OS, Heymen S, Whitehead WE: Biofeedback treatment for functional anorectal disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2004, 29 (3): 153-174.
Kajbafzadeh AM, Sharifi-Rad L, Ghahestani SM, Ahmadi H, Kajbafzadeh M, Mahboubi AH: Animated biofeedback: an ideal treatment for children with dysfunctional elimination syndrome. J Urol. 2011, 186 (6): 2379-2384. 10.1016/j.juro.2011.07.118.
Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M: The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004, 99 (8): 1579-1584. 10.1111/j.1572-0241.2004.30176.x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/13/112/prepub
We would like to express our gratitude to all participating physiotherapists and paediatricians, who contributed generously to the surveys in 2007 and 2011.
The authors declare that they have no competing interests.
MvE substantially contributed to the design of the study and the drafting of the manuscript. MvE, NB, RDB and EB were involved in the design of the study, drafting the manuscript and revising it critically. MB and WV critically revised the paper. All authors have read and approved the final manuscript.
About this article
- Pelvic floor
- Physical therapy
- Randomised controlled trial
- Study protocol